Higher Mortality Risk Linked to ESRD Requiring LVAD Implantation in New Study
May 8th 2022A study found that patients with end stage renal/kidney disease (ESRD) who undergo left ventricular assist device (LVAD) implantation had higher 1-year mortality compared with patients with chronic kidney disease.
Read More
SHEA Updates Guidelines for Central Line-Associated Bloodstream Infection Prevention in Hospitals
May 8th 2022Preventing health-care–associated infections in acute-care hospitals is crucial for patient well-being and health care cost burden, and comprehensive guidelines based on current research are an important aspect of prevention.
Read More
Integrating Analytics With High-Touch Pharmacy Care for Vulnerable Beneficiaries
May 8th 2022UPMC Health Plan, RxAnte, and Mosaic Pharmacy Services outlined how they are operating a value-based pharmacy care management program within Community HealthChoices, Pennsylvania’s managed Medicaid long-term services and supports (LTSS) program, at a recent conference.
Read More
Novel Therapies Targeting Vasoconstriction and Vascular Remodeling May Improve Outcomes in PAH
May 8th 2022Drugs currently marketed for pulmonary arterial hypertension have been able to extend the lives of patients but have shown limitations in their ability to prevent or reverse the disease. A novel combination approach may hold promise in future treatments.
Read More
Cardiac Rehab Linked to Improved Mortality Among Patients With HFrEF
May 6th 2022In this study, outcomes were investigated among a cohort of patients with heart failure with reduced ejection fraction (HFrEF) who participated in a cardiac rehabilitation program post hospital discharge after they survived acute onset of HFrEF.
Read More
Dr Elaine Siegfried on Safety Considerations for JAK Inhibitors in Pediatric Atopic Dermatitis
May 6th 2022Elaine Siegfried, MD, professor of pediatrics and dermatology, Saint Louis University Health Sciences Center, speaks on safety considerations for the use of Janus kinase (JAK) inhibitors in pediatric patients with atopic dermatitis.
Watch
What We’re Reading: Global COVID-19 Deaths; J&J Vaccine Limited; Uterine Cancer Deaths on the Rise
May 6th 2022New global data put the COVID-19 death toll at just under 15 million; the FDA issues a warning limiting use of Johnson & Johnson vaccine; US sees increase in aggressive uterine cancer cases.
Read More
Dr Roxana Siles: Blinded Trials Are Important When Evaluating Chronic Cough Treatment
May 6th 2022Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, addresses the placebo effect seen in clinical trials of chronic cough treatment.
Watch
What’s Required in Order to Fight Medication Use Quality Disparities
May 6th 2022When it comes to making equity improvements and successes sustainable, leadership from the top levels are required, and that means finding champions who are bold, open to collaboration, and willing to explore new partnerships with an open mind, the panel agreed.
Read More
Machine Learning Identifies Predictors of Revision Endoscopic Sinus Surgery
May 5th 2022A machine learning approach identified age and several comorbidities, such as nasal polyps and asthma, as being associated with revision endoscopic sinus surgery among patients with chronic rhinosinusitis.
Read More
At PQA, CMS Veteran Blum Highlights Policy Shifts and Rationale for Latest Rulemaking
May 5th 2022Future quality conversations must recognize what the pandemic has illustrated over the past 2 years—that patients who were in the most dire need of health care, including those with multiple chronic conditions, had the least amount of access, said Jonathan Blum, MPP, the principal deputy administrator and chief operating officer of CMS.
Read More
FDA Approves Enhertu for Use in Metastatic Breast Cancer
May 5th 2022This approval of trastuzumab deruxtecan (Enhertu) follows the March release of data from the DESTINY-Breast03 trial on the anti-HER2 monoclonal antibody, also a HER2-directed antibody-drug conjugate, which indicated superior outcomes vs trastuzumab emtansine.
Read More
Overlapping Comorbidity Risks Found in Patients With Plaque Psoriasis, Palmoplantar Pustulosis
May 5th 2022An overlapping comorbidity profile was observed among patients with plaque psoriasis and palmoplantar pustulosis, although risks of certain comorbid conditions varied between the 2 groups.
Read More